Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 04 Apr 2025

Deciphering ERR Family Genes as Prognostic and Immunological Biomarkers through Pan-Cancer Analysis with Validation in Gallbladder Cancer

in Cancer Immunity and Immunotherapy

Wanwan Gong
Sijia Wen
Yu Chen
Fan Wu
Mengmeng Yang
Ping Sun
Xingmei Guo
Meiqin Li
Daozhen Chen
Hui Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1525635

Review

Published on 03 Apr 2025

Combination therapy with oncolytic viruses for lung cancer treatment

in Cancer Immunity and Immunotherapy

Lei Sun
Qi Zhao
Liyun Miao

Frontiers in Oncology

doi 10.3389/fonc.2025.1524079

203 views

Case Report

Published on 03 Apr 2025

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization

in Cancer Immunity and Immunotherapy

Daniela A. Ferraro
Bettina Bisig
David C. Rotzinger
Fresia Pareja
Edoardo Missiaglia
Ioannis Voutsadakis
Krisztian Homicsko
Antonia Digklia

Frontiers in Oncology

doi 10.3389/fonc.2025.1485386

118 views

Case Report

Published on 01 Apr 2025

Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

in Cancer Immunity and Immunotherapy

Tyler Ruemmele
Rodney Macedo
Mark N. Stein
Hei Ton Chan
Markus Y. Mapara
Céline F. Jacquemont
Ran Reshef

Frontiers in Oncology

doi 10.3389/fonc.2025.1543622

275 views

Mini Review

Accepted on 31 Mar 2025

Cell-Based Immunotherapies for Solid Tumors: Advances, Challenges, and Future Directions

in Cancer Immunity and Immunotherapy

Ting Zhao
Congyue Wang
Bo Li
Yuhan Liu
Wuyang Zhao
Chuang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1551583

Review

Accepted on 31 Mar 2025

Expanding horizons of cancer immunotherapy: hopes and hurdles

in Cancer Immunity and Immunotherapy

Priyanka Vijay Sonar
Anuj Kumar Singh
Sravan Mandadi
Prof. Nilesh Kumar Sharma

Frontiers in Oncology

doi 10.3389/fonc.2025.1511560

Review

Accepted on 31 Mar 2025

Rewiring Lipid Metabolism to Enhance Immunotherapy Efficacy in Melanoma: A Frontier in Cancer Treatment

in Cancer Immunity and Immunotherapy

Jian Cheng
Lihua Xiong

Frontiers in Oncology

doi 10.3389/fonc.2025.1519592

Review

Accepted on 28 Mar 2025

Nanoparticle-Mediated Delivery of Herbal-Derived Natural Products to Modulate Immunosenescence-Induced Drug Resistance in Cancer Therapy: A Comprehensive Review

in Cancer Immunity and Immunotherapy

Lichang Yang
Manman Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1567896

Case Report

Accepted on 27 Mar 2025

A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer

in Cancer Immunity and Immunotherapy

Peipei Mou
Fanghua Li
Feifei Zhao
Yingying Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1517391

Editorial

Published on 27 Mar 2025

Editorial: Immunotherapy: up to date progress in childhood and hematological malignancies

in Cancer Immunity and Immunotherapy

Kishore B. Challagundla
Kausar M. Ansari
Manoj K. Pandey

Frontiers in Oncology

doi 10.3389/fonc.2025.1584101

225 views

Mini Review

Accepted on 26 Mar 2025

Single-Cell RNA Sequencing in Diffuse Large B-Cell Lymphoma: Tumor Heterogeneity, Microenvironment, Resistance, and Prognostic Markers

in Cancer Immunity and Immunotherapy

Linwei Li
Qiwei Li
Rui Niu
Wei Sun
Hua Liang

Frontiers in Oncology

doi 10.3389/fonc.2025.1583250

Original Research

Published on 26 Mar 2025

Integrating multi-omics and machine learning methods reveals the metabolism of amino acids and derivatives-related signature in colorectal cancer

in Cancer Immunity and Immunotherapy

Jian Yue
Huiying Fang
Qian Yang
Rui Feng
Guosheng Ren

Frontiers in Oncology

doi 10.3389/fonc.2025.1565090

292 views

Mini Review

Accepted on 25 Mar 2025

Activation-Induced Cytidine Deaminase in Tertiary Lymphoid Structures: Dual Roles and Implications in Cancer Prognosis

in Cancer Immunity and Immunotherapy

Lv Zhuangwei
Junna Jiao
Wuyang Xue
Xiaoyu Shi
Ruihan Wang
Jinhua Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1555491

Original Research

Published on 25 Mar 2025

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer

in Cancer Immunity and Immunotherapy

Yuquan Yuan
Chunyan Ren
Jin Shu
Keyang Zhu
Ganghui Li
Bao Liu
Jianrong Huang
Yinde Huang
Chengzhi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1560625

337 views

Editorial

Accepted on 24 Mar 2025

Editorial: Mitochondria in the regulation of anti-tumor immunity

in Cancer Immunity and Immunotherapy

Aqu Alu
Yang Wang
Yuan Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1596146

100 views

Case Report

Published on 24 Mar 2025

Promising outcomes of the PD-L1 inhibitor Socazolimab in recurrent and metastatic cervical cancer: a case report

in Cancer Immunity and Immunotherapy

Zichao Xu
Minjie Wang
Long Gong
Guanghong Luo
Yucong Zhang
Yayan Zhou
Zihuang Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1541760

400 views